Comparison Revance Therapeutics (RVNC) with Competitors
Revance Therapeutics (RVNC) industry is Biotechnology.
Profit Margin
RVNC-63.65%
Industry-0.13%
Upside-63.52%
Operating Margin
RVNC-53.87%
Industry-2073.25%
Upside+2019.38%
Debt-to-Equity
RVNC1477.84%
Industry29.76%
Upside+4866.00%
Free Cash Flow Yield
RVNC-53.98%
Industry-1.94%
Upside-52.04%
P/E
RVNC-1.86
Industry-18.88
Upside+1701.91%
P/S
RVNC1.48
Industry9.28
Upside-84.05%
P/B
RVNC-2.33
Industry4.70
Upside-703.07%